Economic burden in patients (pt) with CLL/SLL (CLL) who received ≥ 2 prior lines of therapy (LOT), including a Bruton tyrosine kinase inhibitor (BTKi): A SEER-Medicare analysis. This is an ASCO ...

This series of Special Features takes an in-depth look at the science behind some of the most debated nutrition-related topics, weighing in on the facts and debunking the myths. Share on Pinterest ...

Dianthus achieved its NASDAQ listing last year via a merger with Magenta Therapeutics. The company is focused on development of a single drug candidate, DNTH-103, which targets the complement system, ...

MANASSAS, Va., Jan. 5, 2026 /PRNewswire/ -- PureHealth Research announces their collection of supplements for nervous system support, designed for biohackers, executives, and wellness optimizers ...